ATE420108T1 - Verfahren zur herstellung von preparationen aus milchprodukten, welche wachstumsfaktoren (tgf- beta und igf-1), lactoperoxidase und immunglobuline mit niedriger gegenseitiger verunreinigung enthalten - Google Patents
Verfahren zur herstellung von preparationen aus milchprodukten, welche wachstumsfaktoren (tgf- beta und igf-1), lactoperoxidase und immunglobuline mit niedriger gegenseitiger verunreinigung enthaltenInfo
- Publication number
- ATE420108T1 ATE420108T1 AT02747753T AT02747753T ATE420108T1 AT E420108 T1 ATE420108 T1 AT E420108T1 AT 02747753 T AT02747753 T AT 02747753T AT 02747753 T AT02747753 T AT 02747753T AT E420108 T1 ATE420108 T1 AT E420108T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factors
- igf
- tgf
- beta
- lactoperoxidase
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title abstract 3
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 title abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 108010023244 Lactoperoxidase Proteins 0.000 title 1
- 102000045576 Lactoperoxidases Human genes 0.000 title 1
- 235000013365 dairy product Nutrition 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
- 239000012535 impurity Substances 0.000 title 1
- 229940057428 lactoperoxidase Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000011347 resin Substances 0.000 abstract 3
- 229920005989 resin Polymers 0.000 abstract 3
- 239000003446 ligand Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 abstract 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01202795 | 2001-07-20 | ||
| EP01202794 | 2001-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420108T1 true ATE420108T1 (de) | 2009-01-15 |
Family
ID=26076963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02747753T ATE420108T1 (de) | 2001-07-20 | 2002-07-22 | Verfahren zur herstellung von preparationen aus milchprodukten, welche wachstumsfaktoren (tgf- beta und igf-1), lactoperoxidase und immunglobuline mit niedriger gegenseitiger verunreinigung enthalten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040219225A1 (de) |
| EP (1) | EP1409538B1 (de) |
| CN (1) | CN1555384B (de) |
| AT (1) | ATE420108T1 (de) |
| AU (1) | AU2002318066B2 (de) |
| CA (1) | CA2454548A1 (de) |
| DE (1) | DE60230763D1 (de) |
| DK (1) | DK1409538T3 (de) |
| NZ (1) | NZ530704A (de) |
| WO (1) | WO2003008447A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2827290B1 (fr) | 2001-07-13 | 2004-07-09 | Pierre Jouan Biotechnologies Sa | Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques |
| FR2889068B1 (fr) * | 2005-07-29 | 2012-03-02 | Cie Laitiere Europeenne | Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques |
| FR2901707B1 (fr) | 2006-05-31 | 2017-09-29 | Lab Francais Du Fractionnement | Composition de facteur vii recombinant ou transgenique, chaque molecule de facteur vii possedant deux sites de n-glycosylation a motifs glycanniques definis |
| FR2910786B1 (fr) | 2006-12-29 | 2017-08-11 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies (Lfb) | "procede d'extraction d'une proteine presente dans du lait" |
| FR2912310B1 (fr) | 2007-02-13 | 2009-08-07 | Kasan Sarl | Nouvelles compositions cosmetiques et/ou pharmaceutiques et leurs applications. |
| WO2008119185A1 (en) * | 2007-04-03 | 2008-10-09 | Advitech Inc. | Process for the manufacture of a dairy-based anti-inflammatory composition |
| WO2009046168A1 (en) | 2007-10-02 | 2009-04-09 | Avaxia Biologics, Inc. | Antibody therapy for use in the digestive tract |
| US8367354B2 (en) * | 2008-10-24 | 2013-02-05 | Mead Johnson Nutrition Company | Methods for determining the levels of TGF-β in a composition |
| US8861162B2 (en) * | 2010-03-09 | 2014-10-14 | Honeywell International Inc. | High power solid state power controller (SSPC) solution for primary power distribution applications |
| CA2827850A1 (en) * | 2011-02-22 | 2012-10-18 | Avaxia Biologics, Inc. | Polyclonal antibody compositions |
| AU2013204850B2 (en) * | 2012-10-08 | 2015-06-25 | Murray Goulburn Co-Operative Co. Limited | Improved process for purifying milk proteins and products thereof |
| AU2013204858B2 (en) * | 2012-10-08 | 2015-06-25 | Saputo Dairy Australia Pty Limited | Improved process for purifying milk proteins and products thereof |
| CN108676784B (zh) * | 2018-06-06 | 2021-04-27 | 中国农业科学院北京畜牧兽医研究所 | 一种牛乳中乳过氧化物酶的纯化方法 |
| US11109604B2 (en) | 2019-05-09 | 2021-09-07 | Memtec LLC | Dairy processing systems and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8806893D0 (en) * | 1988-03-23 | 1988-04-27 | Unilever Plc | Cosmetic composition |
| NL1005677C2 (nl) * | 1997-03-27 | 1998-09-29 | Campina Melkunie Bv | Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan. |
| GB9708641D0 (en) * | 1997-04-29 | 1997-06-18 | Knoll Ag | Enzyme concentrate |
| WO2001025276A1 (en) * | 1999-10-06 | 2001-04-12 | Campina B.V. | Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination |
-
2002
- 2002-07-22 NZ NZ530704A patent/NZ530704A/en not_active IP Right Cessation
- 2002-07-22 US US10/484,255 patent/US20040219225A1/en not_active Abandoned
- 2002-07-22 AU AU2002318066A patent/AU2002318066B2/en not_active Ceased
- 2002-07-22 CA CA002454548A patent/CA2454548A1/en not_active Abandoned
- 2002-07-22 EP EP02747753A patent/EP1409538B1/de not_active Expired - Lifetime
- 2002-07-22 DE DE60230763T patent/DE60230763D1/de not_active Expired - Fee Related
- 2002-07-22 CN CN028182111A patent/CN1555384B/zh not_active Expired - Fee Related
- 2002-07-22 WO PCT/NL2002/000496 patent/WO2003008447A1/en not_active Ceased
- 2002-07-22 DK DK02747753T patent/DK1409538T3/da active
- 2002-07-22 AT AT02747753T patent/ATE420108T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60230763D1 (de) | 2009-02-26 |
| EP1409538B1 (de) | 2009-01-07 |
| WO2003008447A1 (en) | 2003-01-30 |
| EP1409538A1 (de) | 2004-04-21 |
| CN1555384B (zh) | 2010-05-26 |
| WO2003008447A8 (en) | 2003-03-20 |
| AU2002318066B2 (en) | 2007-10-11 |
| NZ530704A (en) | 2005-07-29 |
| CA2454548A1 (en) | 2003-01-30 |
| US20040219225A1 (en) | 2004-11-04 |
| CN1555384A (zh) | 2004-12-15 |
| DK1409538T3 (da) | 2009-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE420108T1 (de) | Verfahren zur herstellung von preparationen aus milchprodukten, welche wachstumsfaktoren (tgf- beta und igf-1), lactoperoxidase und immunglobuline mit niedriger gegenseitiger verunreinigung enthalten | |
| ATE277950T1 (de) | Verfahren zur herstellung von immunoglobulinen zur intravenösen verabreichung und anderen immunoglobulin-produkten | |
| UA48105C2 (uk) | ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ) | |
| DE69300674T2 (de) | Verfahren zur isolierung von lactoferrin und lactoperoxidase aus milch und milchprodukten. | |
| DE69032806D1 (de) | Verfahren zur isolierung und reinigung von rezeptoren für transferrin und lactoferrin von bakterien und herstellung von impfstoffen, die sie enthalten | |
| DE69424687D1 (de) | Verfahren zur isolierung von proteinen aus milch | |
| ATE321781T1 (de) | Verfahren zur herstellung einer proteinhaltigen fraktion, mit beta-tgf in aktivierter form bereichert, sowie die so erhaltene fraktion und deren therapeutische verwendungen | |
| DE182442T1 (de) | Rekombinante dns-molekuele und verfahren zur herstellung derselben. | |
| ATE90690T1 (de) | Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. | |
| DE69830315D1 (de) | Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung | |
| ATE544739T1 (de) | Verfahren zur rückgewinnung von organischen verbindungen aus diesen enthaltenden wässrigen strömen | |
| DE69428356T2 (de) | Reinigung von plasmaproteinen | |
| SI2895188T1 (en) | CORRECTED QUALITY ETHANERCEPT WITH HIGH QUALITY AND EXCELLENT EXPERIENCE | |
| DE69925870D1 (de) | Verfahren zur bereitstellung von wachstumsfaktozubereitungen (tgf-beta und igf-1) mit niedriger gegenseitiger verunreinigung aus milchprodukten | |
| CA2018511C (en) | Process for the preparation of purified albumin solutions | |
| EP0764658B1 (de) | Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen | |
| ATE116348T1 (de) | Verfahren zur zubereitung beständiger bitumen- polymermischungen. | |
| EP0525502A1 (de) | Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen | |
| DE69300551D1 (de) | Verfahren zur Herstellung von (3R,4R)-3-Hydroxy-4-Hydroxymethyl-4-Butanolid. | |
| DE69519203D1 (de) | Verfahren zur Herstellung von Extrakten enthaltende polyphenalische oligomere Verbindungen von Catechin-Typ, aus pflanzenartigen Quellen, und diese erhaltene Extrakte | |
| DE3787336D1 (de) | Verfahren zur Herstellung von Copolyesters, die Anisotropie in geschmolzenem Zustand zeigen. | |
| DE60008476D1 (de) | Verfahren zur Herstellung von 2,6-Dimethylnaphthalen | |
| DE69222361D1 (de) | Verfahren zur Isolierung von Proteinen aus Milch und Verfahren zur Behandlung von Milch | |
| DE69016017D1 (de) | Verfahren zur reinigung von hemin, neues heminderivat und verfahren zur herstellung. | |
| DE69022014D1 (de) | Verfahren zur Herstellung von S-(+)-3-Halogeno-1,2-propandiol durch Behandlung mit Mikroorganismen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |